next-generation sequencing

NATICK, MASSACHUSETTS, AND RENO, NEVADA, Aug 27, 2026 Pillar Biosciences, Inc. and Hamilton Company have announced the validation and...

Guilford, Connecticut, August 20, 2026 Hyperfine announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s...

Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...

Burlington, North Carolina, USA, August 10, 2026 Labcorp has announced that the U.S. Food and Drug Administration (FDA) has...

HOUSTON & LAKE FOREST, Calif., July 16, 2026 Plus Therapeutics and Genomic Testing Cooperative (GTC) announced a strategic collaboration...

IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...

CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...

VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...

NASHIK, India, May 21, 2026 Datar Cancer Genetics (DCG) has achieved a major milestone in precision oncology after receiving...

Boston, MA – December 2025 – The global Clinical Oncology Next-Generation Sequencing (NGS) market is expanding rapidly as cancer...